Ready to take your innovation to market?
Work shoulder-to-shoulder with a family-owned CDMO and pharmaceutical supplier that answers quickly, solves early, and keeps your progress steady. Decisions feel clearer with us beside you.
Kirsten Lingbeek-Brummelhuis joined Ofichem as Chief Operating Officer at the beginning of 2024. She holds a master’s degree in pharmacy (PharmD) form the University of Utrecht and an executive MBA from TIAS School for Business and Society.
Before joining Ofichem, Kirsten has held various R&D leadership positions in Solvay Pharmaceuticals (Abbott) and Genzyme (Sanofi). She played a key position in growing Xendo, a Dutch consultancy company, into a highly successful international player acquired by the ProPharma Group. She has extensive experience in product development, (clinical) supply chain management, CMC, Regulatory Affairs.
In the following years she dedicated her time to various initiatives and start-ups to improve access to medicines for all. This drives her every day in her work at Ofichem.
Work shoulder-to-shoulder with a family-owned CDMO and pharmaceutical supplier that answers quickly, solves early, and keeps your progress steady. Decisions feel clearer with us beside you.